US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
アメリカ
USOTC
InPost SA (PK) (INPOY) 銘柄情報

InPost SA (PK) (INPOY)

8.90

0.255

(2.95%)

終了 7月5日 5:00AM

InPost SA (PK) (INPOY) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

8.90

( 2.95% )

買値

8.57

売値

8.95

出来高

2,242

8.639 日の範囲 8.90

5.28 52 週間の範囲 9.17

時価総額

前日終値

8.645

始値

8.765

時刻

最終取引時間

財務取引量

US$ 19,640

VWAP

8.7602

平均取引量 (3 か月)

US$ 1,186,563

発行済株式数

499,942,609

配当利回り

PER

68.18

1 株当たり利益 (EPS)

0.97

歳入

15.62B

純利益

482.8M

InPost S.A., together with its subsidiaries, operates as an out-of-home e-commerce enablement platform providing parcel locker services in Poland and other European countries. InPost S.A. was founded in 1999 and is based in Luxembourg, Luxembourg. InPost S.A., together with its subsidiaries, operates as an out-of-home e-commerce enablement platform providing parcel locker services in Poland and other European countries. InPost S.A. was founded in 1999 and is based in Luxembourg, Luxembourg.

セクター

Industrials

業界

Corporate Services

ウェブサイト

inpost.eu

本社

Luxembourg, Luxembourg

設立

1999

InPost SA (PK) is listed in the Industrials sector of the その他OTC with ticker INPOY. The last closing price for InPost (PK) was US$8.65. Over the last year, InPost (PK) shares have traded in a share price range of US$ 5.28 to US$ 9.17.

InPost (PK) currently has 499,942,609 shares in issue. The market capitalisation of InPost (PK) is US$4.45 billion. InPost (PK) has a price to earnings ratio (PE ratio) of 68.18.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.225	2.59365994236	8.675	8.9	8.5	10116	8.66946497	CS
4	0.03	0.338218714769	8.87	8.933	8.5	8844	8.72716989	CS
12	0.09	1.02156640182	8.81	8.99	8.49	11751	8.80034977	CS
26	2.86	47.3509933775	6.04	9.17	5.95	51724	8.47029879	CS
52	1.1	14.1025641026	7.8	9.17	5.28	64522	7.11080137	CS
156	3.7825	73.9130434783	5.1175	10.165	4.62	32390	7.35220968	CS
260	-0.81	-8.34191555098	9.71	11.34	0.01098	23832	6.82015482	CS

INPOY - Frequently Asked Questions (FAQ)

What is the current InPost SA (PK) share price?

The current share price of InPost SA (PK) is US$ 8.90

How many InPost SA (PK) shares are in issue?

InPost SA (PK) has 499,942,609 shares in issue

What is the market cap of InPost SA (PK)?

The market capitalisation of InPost SA (PK) is USD 4.45B

What is the 1 year trading range for InPost SA (PK) share price?

InPost SA (PK) has traded in the range of US$ 5.28 to US$ 9.17 during the past year

What is the PE ratio of InPost SA (PK)?

The price to earnings ratio of InPost SA (PK) is 68.18

What is the cash to sales ratio of InPost SA (PK)?

The cash to sales ratio of InPost SA (PK) is 2.12

What is the registered address of InPost SA (PK)?

The registered address for InPost SA (PK) is 70, route d'Esch, Luxembourg, 1470

What is the InPost SA (PK) website address?

The website address for InPost SA (PK) is inpost.eu

Which industry sector does InPost SA (PK) operate in?

InPost SA (PK) operates in the Corporate Services sector

GoodGuyBill

GoodGuyBill 5分前

$35 billion is far too low for a treatment that will treat all tumor-based cancers (and we are not even discussing DIRECT, the combo patent, etc).

santafe2

santafe2 9分前

And since we're applying more detail than most will care about, let me add that this is Jefferson and his committee presenting the draft of the declaration, not the signing. Thanks for your input here.

Johnnycombat10

Johnnycombat10 9分前

I'm not counting on shorts. I'm counting on progress with DBMM.

SonicProphet49

SonicProphet49 12分前

Cryptocurrency Recovery Services: Why Acting Fast Can Make a Difference

Recovering Lost or Stolen Cryptocurrency: The Importance of Time

The cryptocurrency market continues to grow, bringing new opportunities for investors, traders, and businesses worldwide. Unfortunate

Philbot

Philbot 16分前

Valid points. Won't it get delisted by not paying its annual listing dues or annual filing statements? It probably should have been auto-delisted by now.

GoodGuyBill

GoodGuyBill 21分前

Thanks. Wish I could return the complement.

https://investorshub.advfn.com/uimage/uploads/2026/7/4/rlzkdBadpost.jpg

m0n

Imagine having a product since 2009 LoL.
Cant even pay the bills and continue to have decades upon decadesof $2.2 million in deficits. LOL
No One is Fooled

m0n

How many shareholders have passed away? I m aware of one but feel there’s more.
I FU S website has ionic studies from 2009. LoL
30 YEARS IS FASTLY APPROACHING! LoL
Same o Same o, Keep the awareness on the possibilities LoL.
No One is Fooled

barnyarddog

barnyarddog 33分前

AI Overview - Avalanche Treasury Co. (ticker: AVAT) is a Nasdaq-listed operating company that provides public market investors with direct exposure to the Avalanche blockchain ecosystem.

Rather than merely stockpiling digital assets, AVAT actively allocates capital across the Avalanc

m0n

Past 6 months WIP $150 &$130k LoL
Can’t even pay the bills without door knocking for SSI $$$ in January 2026LoL
What a Joke!
No One is Fooled

TightCoil

TightCoil 43分前

Glen Bradford - Looks Like Trump Team Simply Maximizing Frannie IPO (OTCMKTS:FNMAS)
Seeking Alpha - 17 hours ago

TechBullion
Could Pepeto Be the Best Crypto Presale to Buy as
Fannie Mae Opens the Door to Crypto Mortgages?
5 hours ago

weenphan

weenphan 50分前

https://www.otcmarkets.com/stock/CVALF/profile

Kool Aid Man

Kool Aid Man 51分前

Measly $44k left in the gas tank

40 million shares left to issue x .0011

No one goes public if they intend to self finance operations. The whole point is to print and sell shares to raise money...not to reward old bag holders who were conned by Miro years ago. Why split

jondoeuk

jondoeuk 52分前

Calling this the "gold standard" doesn't answer all the underlying concerns. This isn't a refinement of the original external-control analysis either. It uses a completely different set of external comparator trials. That means the reported survival estimate depends on which external patients are se

manibiotech

manibiotech 54分前

Yes we all know that . The previous external control arm patients were “external” , and the one’s in new PSM analysis are also different ‘external’ patients with patient level propensity matching ( so even better controls) and show even better treatment benefit . So again, what is the point you are

Naught

Naught 55分前

Should we expect some notices from. PAC in the very near term then...?

weenphan

weenphan 55分前

I posted on the PCHM board for over a decade. I bought PCHM as low as .0013 and sold stock as high as $5 plus. It was a once in a lifetime percentage gainer. My aliases were LMLYP, Rosesarefree and GeneandDean, which all are references to a band Ween. I'm weenphan on this board.

newflow

newflow 55分前

Ron, Dissolved vs Extinct
No Altaba distributed immediately before dissolution, can you find any company distributing value to equity holders after its complete dissolution long-form or regular Dissolution.
Gemini's Response:
It is important to clarify a key point about Delaware

DA88

Can someone explain who this guy is and why his perspective matters? Love that he is positive, but he doesn’t look like he is anything more than a shareholder.

PickStocks

PickStocks 59分前

Yes….but we do not have anything to do with Paladin. So it means nothing which is easily verified by a simple phone call….

jondoeuk

jondoeuk 1時間前

Whether this particular analysis has been submitted is something nobody outside NWBO and the MHRA knows.

jondoeuk

jondoeuk 1時間前

This is not simply a refinement of the published JAMA Oncology analysis. It's a different external-control analysis built from a different pool of comparator trials. The fact they constructed a propensity-score matched analysis using individual patient data from AVAGLIO, CENTRIC, and CORE, means the

ihorchu

ihorchu 1時間前

A fantastic day to remember! Since no humidity here, heat is very tolerable.

UraniumX Discovery

Genesis REIT Socimi

Oscar Properties Holding...

Ci Doubleline Total Retu...

American Century ICAV

0.287% until 20apr2028 0...

Ci Canadian Investment C...

Deutsche Real Estate

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。